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Abstract

Primary cardiac tumors are a rare entity compared to tumors that metastasize to the heart.
Patients with such tumors may be asymptomatic. Many cases are found incidentally
during evaluation of an unrelated medical condition. It is important for the clinician to
have a high index of suspicion when evaluating a patient presenting with signs and
systemic symptoms concerning for possible malignancy, plus cardiac specific symptoms
or complications. These can include new onset dyspnea, congestive heart failure,
arrhythmias or murmurs varying with body positions. Imaging, particularly the use of
cardiac echocardiography, remains the cornerstone of diagnosis, and may be combined
with new imaging modalities of cardiac CT and MRI. The aim of this paper is to describe
the epidemiology and pathophysiology of the various benign and malignant primary
cardiac tumors.

Primary Cardiac Tumors

Primary cardiac tumors are a rare entity. They have an autopsy frequency of 0.001% –
0.28%. By contrast metastatic involvement of the heart is far more common, occurring in
1.5% - 21% of all autopsies performed on patients (1,2,3). Approximately three-quarters
of primary heart tumors are benign with atrial myxomas comprising three-quarters of
those. Of the 25% of primary cardiac tumors that are malignant, approximately three-
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quarters are sarcomas (4). The aim of this paper is to describe the epidemiology,
pathology, and pathophysiology of the various benign and malignant primary cardiac
tumors.

Presentation
Primary cardiac tumors may be asymptomatic with up to 12% of cases found incidentally
during evaluation of an unrelated medical condition (5). They often present in a subtle
manner though dramatic presentations are sometimes encountered. In the case of
malignant disease there may be direct invasion of the myocardium, causing arrhythmias
or heart block, or pericardial effusion which may progress to life-threatening tamponade.
They may also produce signs and symptoms of heart failure by causing progressive
valvular regurgitation (6). Pulmonary venous hypertension secondary to physical
obstruction of a cardiac chamber filling may result in dyspnea or frank pulmonary edema.
Systemic emboli may occur to the brain or extremities. Constitutional symptoms, such as
fevers and arthralgias, can sometimes be present (7). Interestingly, body position may
influence the severity of symptoms due to the movement of tumor within the heart, and a
characteristic early diastolic “tumor plop” may be heard on auscultation.

Benign Cardiac Tumors
Atrial Myxomas
Atrial myxomas are the most common primary cardiac tumors, comprising up to 50% of
all primary cardiac tumors (figure 1) (8). Myxomas occur with increased frequency in the
third to sixth decades of life (9). Up to 90% occur in the left atrium where they are
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usually attached to the atrial septum, in or adjacent to the fossa ovalis (10). The
remainder occur in the right atrium or, infrequently, in the ventricles. They are more
common in women, with a 2:1 female preponderance. Patients can present with systemic
embolization (cerebral or peripheral) or with symptoms due to obstruction of the mitral
valve. They will often have constitutional symptoms such as anemia, fever, and weight
loss. Additionally, the erythrocyte sedimentation rate is often increased (5).

“Syndrome myxoma” refers to one of several genetic disorders which should be
suspected in patients younger than 40 years who present with multiple cardiac myxomas.
These can include biatrial, ventricular and recurrent myxomas. These syndromes are
typically associated with blue nevi, cutaneous lentiginosis, peripheral tumors and
endocrine neoplasms. Myxoma syndromes include LAMB (lentigines, atrial myxomas,
mucocutaneous myxomas, and blue nevi), NAME (nevi, atrial myxomas, myxoid
neurofibroma, and ephelides and Carney syndrome (atrial, cutaneous and mammary
myxomas, lentigines, blue nevi, endocrine disorders and testicular tumours)
If diagnosed, all first degree relatives should be screened for the condition (11,12).

Structurally, most myxomas have a stalk, are gelatinous, and have a broad base. The
surface may be friable or villous. There can be different consistencies within the
myxoma, including areas that may be hemorrhagic or cystic (11,13).

5

The diagnosis of atrial myxoma by imaging requires prompt resection since there is a risk
of embolization and sudden death. Surgical outcome is generally good, with a 20-year
survival rate of 85%. However, there is a recurrence rate after resection of approximately
5%. Therefore careful, serial follow-up is required (7).

Papillary Fibroelastomas
Papillary fibroelastomas are rare, comprising less than 10% of all primary cardiac tumors
examined at autopsy or post resection (figure 2a, figure 2b, figure 3) (14). They are the
most common valvular tumor and the third most common primary cardiac tumor (after
myxoma and fibroma). Papillary fibroelastomas have been referred to by various names,
including myxofibroma, cardiac papilloma, papillary fibroma and giant Lambl’s
excrescences. Giant Lambl's excrescences are caused by wear-and tear of valves,
commonly the aortic valve, and comprise a densely hyalinized central core lined by
endocardial-type spindle cells. Papillary fibroelastomas occur predominantly in males
with a mean age at the time of detection of 60 years. Although the natural history of these
tumors is not fully known, lesions have been observed to develop over periods ranging
from 6 months to 15 years (15,16). In 90% of cases these tumors are found on cardiac
valves. Other sites include the coronary sinus os, right ventricular endocardium, the left
ventricular septum, and the both the right and left outflow tracts. Lesions usually occur
on left-sided cardiac valves, with approximately 36% involving the aortic valve and 29%
affecting the mitral valve (17,18). In one case series (19), where lesions were identified
pathologically from surgical specimens, tumors tended to occur in areas of endocardial
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irritation, including degenerative aortic valve sclerosis, mitral valve prolapse, prior
surgical repair of congenital ventriculoseptal defect, systolic anterior motion of mitral
valve, and hypertrophic cardiomyopathy. Some lesions occur as congenital
malformations, including a case of a 9-month-old child with a tricuspid valve tumor
obstructing the right ventricular outflow tract, but most are acquired (20).

The majority of papillary fibroelastomas are solitary with multiple tumors seen in <10%
of patients. Most lesions are less than 20mm in their largest diameter. They have been
described pathologically as having the appearance of sea anemones, with multiple
papillary fronds arising from a central stalk (15,21).

Papillary fibroelastomas are rarely cause valvular dysfunction. However, left-sided
tumors can be associated with serious symptoms including angina, transient ischemic
attacks and sudden death. While tumor embolization may be responsible for the central
neurological events it is also possible that the tumors serve as a nidus for clot formation
which may subsequently embolize (22,23).

Echocardiographically, the distinguishing feature between papillary fibroelastoma and a
Lambl’s excrescence is size, with fibroelastomas being larger. Myxomas can usually be
distinguished from fibroelastomas based on location with the former usually attached to
the atrial septum and the latter to a left sided valve (24).
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The size of the lesion does not always correlate with the risk of developing serious
morbidity and there may be no warning signs before a serious event. Surgical removal of
lesions (in the absence of major surgical contraindications) may therefore be considered
(25,26).

Rhabdomyomas
These lesions occur almost exclusively in children, in the majority before one year of age.
They are the most common primary cardiac neoplasm in children. Rare cases have been
reported in adults. These lesions are usually found on the ventricular walls or the
atrioventricular valves (27). Microscopically lesions demonstrate striated muscle fibers
with features typical of myocytes. Symptoms may result from arrhythmias or mechanical
complications due to obstruction of blood flow in the heart. The majority of
rhabdomyomas regress spontaneously (28).

Fibromas
Cardiac fibromas are the second most common pediatric cardiac tumors. They may also
occur in adults. Fibromas usually arise in ventricular muscle. Histologically, they have
features of fibroblasts and may give a false appearance of malignant myocardial
infiltration due to encompassing areas of myocardium (28,29). Symptoms are due to
conduction abnormalities, resulting in arrhythmias and sudden cardiac death, and
mechanical obstruction of blood flow within the heart, which can lead to congestive heart
failure. Unlike rhabdomyomas, fibromas do not regress on their own in children and
often require resection (11).
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Lipomas
Lipomas comprise a benign accumulation of adipocytes. They may occur anywhere in the
heart and can occur in the pericardium, subendocardium, subepicardium, and intra-atrial
septum. Tumor size ranges from a few centimeters to many kilograms. Symptoms, when
they occur, are due to arrhythmias and conduction block or may be related to anginal pain
due to compression of coronary arteries (30,31). These tumors tend to progressively
enlarge and, when symptomatic, need to be excised.

Lipomatous septal hypertrophy
Lipomatous septal hypertrophy is due to increased growth of adipocytes within the atrial
septum. They occur only in the interatrial septum. Found mainly among elderly and
obese patients it is not a true cardiac tumor (32). The accumulation of fat in the septum
may result in atrial arrhythmias or atrio-ventricular conduction abnormalities. In the
absence of these effects these no treatment is required (33).

Malignant Cardiac Tumors
Sarcomas
Approximately 25% of primary cardiac tumors are malignant. The majority are sarcomas
(Figure 4). Sarcomas have variable presentations, depending more on tumor location
than pathological type. This makes early diagnosis difficult. Patients may present with
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vague symptoms such as dyspnea, or more dramatically with pulmonary hemorrhage or
even cardiovascular collapse.

Angiosarcomas
Angiosarcomas occur most frequently in the adult population and are more common in
males. They have a propensity to occur on the right side of the heart, especially the right
atrium (34,35). Lesions may be large, replacing the atrial wall and extending into the
chamber, even occasionally completely filling it. They can invade the vena cava,
tricuspid valve and pericardium. Mesenchymal in origin they are composed of malignant
cells forming vascular channels. Microscopically, a sinusoidal pattern is often seen. There
are two clinicopathological forms of angiosarcoma. In the first type tumor deposits
involve the epicardium or pericardium, are usually small and asymptomatic, and are
associated with skin lesions of or risk factors for Karposi’s sarcoma. The second type
involves large symptomatic lesions, occurring in the right atrium, which are not
associated with Karpoi’s sarcoma or its risk factors. Treatment with chemotherapy or
radiation does not relieve symptoms as well as tumor resection, although survival data on
surgically treated lesions in both types are rare (36).

Rhabdomyosarcomas
Rhabdomyosarcoma is the second most common primary sarcoma. These tumors occur
equally in both sexes and are multicentric in up to 60% of patients. Patients often present
with non-specific symptoms. They may occur in any cardiac chamber, are bulky and
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invasive, grow rapidly, and often have invaded pericardium by the time of diagnosis (37).
Surgical resection of small tumors is often attempted, but due to local and distant
metastasis, and poor response to radiation and chemotherapy, prognosis is poor (38).

Leiomyosarcomas
Primary leiomyosarcomas of the heart are extremely rare and comprise less than 0.25%
of all primary cardiac tumors. They are usually found in the left atrium and histologic
demonstrates spindle-shaped cells. Presenting symptoms result from arrhythmias,
including sudden death, and hemopericardium (39). Patients may also present with
symptoms due to obstruction which may mimic pulmonary thromboembolism or mitral
valve stenosis. These tumors are highly aggressive, spread systemically, have early local
resurrence, and are locally invasive. Resection is mainly palliative. Extensive resection
followed by chemotherapy may improve prognosis (39,40).

Imaging
Diagnosis of intracardiac tumors is often possible by transthoracic echocardiography
(TTE), with a detection rate of 95.2%. In cases where there is doubt or image quality is
not optimal, transesophageal echocardiography (TEE) may be attempted. (41). Both CT
scanning and cardiac MRI produce high resolution images of the heart. Both can provide
additional information regarding extent of tumor within the heart or into adjacent
extracardiac structures, and may help in making histologic distinctions. Contrast
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enhancement can be used to differentiate tumors from thrombi since thrombi do not
usually show enhancement and fat-suppression techniques may further define tumors
such as lipomas (42). Finally, these techniques provide good definition of lesions prior to
any surgical interventions.

Conclusion
Primary cardiac tumors are rare with three-quarters being benign (mostly myxomas). The
remaining 25% are malignant, mainly sarcomas. Diagnosis often requires a high index of
suspicion as presentations can be variable. Signs and symptoms can include new onset
dyspnea, congestive heart failure, arrhythmias or murmurs varying with body positions.
Echocardiography remains the cornerstone of diagnosis but cardiac CT and MRI can
often provide additional useful information. Surgical resection is the primary treatment
modality, with radiotherapy and chemotherapy being largely palliative.
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Figure 1
Sixty-four year old man who presented with vague neurologic symptoms. Transthoracic
echo revealed a left atrial mass at the junction of the atrial septum and anterior mitral
leaflet prompting this transesophageal echocardiogram. Surgical resection demonstrated a
myxoma.

Figure 2a
In-situ operative field view of left atrial appendage showing attached mass which was
histologically diagnosed as papillary fibroelastoma.

Figure 2b
Histological preparation of papillary fibroelastoma showing avascular papillary structures
lined with endothelial cells.

Figure 3
Intra-operative image of atrioventricular papillary fibroelastoma.

Figure 4
Thirty-five year old woman who presented with dyspnea. Transthoracic echocardiogram
showed a large irregular left atrial mass prompting this transesophageal echocardiogram.
Surgical resection demonstrated a myxofibrosarcoma.
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